GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Ending Cash Position

NKGen Biotech (NKGen Biotech) Ending Cash Position : $0.28 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Ending Cash Position?

NKGen Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 was $0.28 Mil.

NKGen Biotech's quarterly Ending Cash Position increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.28 Mil) and increased from Dec. 2023 ($0.28 Mil) to Mar. 2024 ($0.28 Mil).

NKGen Biotech's annual Ending Cash Position declined from Dec. 2021 ($0.35 Mil) to Dec. 2022 ($0.12 Mil) but then increased from Dec. 2022 ($0.12 Mil) to Dec. 2023 ($0.28 Mil).

NKGen Biotech Ending Cash Position Historical Data

The historical data trend for NKGen Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Ending Cash Position Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Ending Cash Position
0.35 0.12 0.28

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial 0.12 0.75 - 0.28 0.28

NKGen Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NKGen Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.117+0.159
=0.28

NKGen Biotech's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.276+0.008
=0.28

NKGen Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Ending Cash Position
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.